Characteristics | Total n = 79 | Idiopathic n = 34 | Infection triggered n = 25 | Non-infection triggered n = 20 | p |
---|---|---|---|---|---|
Patients’ characteristics | |||||
 Age | 74 (62 to 85) | 75 (64 to 86) | 75 (63 to 82) | 72 (62 to 85) | 0.876 |
 Sex | 66 | 29 | 19 | 18 | 0.507 |
 Men (%) | 83.54% | 85.29% | 76% | 90% |  |
 Smoking history | 61 | 25 | 18 | 18 | 0.271 |
  Yes (%) | 77.22% | 73.53% | 72% | 90% |  |
 Current smoker | 13 | 5 | 4 | 4 | 0.592 |
  (%) | 16.46% | 14.71% | 16% | 20% |  |
Symptoms | |||||
 High fever | 43 | 15 | 18 | 10 | 0.094 |
  Yes (%) | 54.43% | 44.12% | 72% | 50% |  |
 Sore throat | 35 | 8 | 22 | 5 | 0.0001 |
  Yes (%) | 44.31% | 23.52% | 88% | 25% |  |
 Worsening cough | 50 | 22 | 16 | 12 | 0.808 |
  Yes (%) | 63.29% | 64.77% | 64% | 60% |  |
 Worsening dyspnea | 75 | 32 | 24 | 19 | 0.926 |
  Yes (%) | 94.94% | 94.12% | 96% | 95% |  |
Pre-existing CF-IIPs | Â | Â | Â | Â | 0.072 |
 IPF | 59 | 25 | 19 | 15 |  |
 UCIP | 20 | 9 | 6 | 5 |  |
Prior treatment | Â | Â | Â | Â | 0.177 |
 No treatment | 47 | 17 | 14 | 16 |  |
 Corticosteroid | 9 | 3 | 2 | 4 |  |
 Corticosteroid + IS | 6 | 4 | 2 | 0 |  |
 Pirfenidone | 9 | 4 | 5 | 0 |  |
 Nintedanib | 4 | 3 | 1 | 0 |  |
 Corticosteroid + Nintedanib | 4 | 3 | 1 | 0 |  |
HRCT pattern at AE-IIPs onset | Â | Â | Â | Â | 0.471 |
 Diffuse | 34 | 17 | 7 | 10 |  |
 Multifocal | 14 | 7 | 5 | 2 |  |
 Peripheral | 31 | 10 | 13 | 8 |  |
Pulmonary function | |||||
 P/F ratio | 168 (83.2 to 344.1) n = 79 | 173.7 (54.4 to 380.9) n = 34 | 213.3 (46.7 to 476.7) n = 25 | 134.2 (55.5 to 458.6) n = 20 | 0.201 |
 FVC (L) | 2.35 (0.94 to 3.01) n = 39 | 2.29 (1.53 to 3.07) n = 18 | 1.51 (0.78 to 2.76) n = 11 | 2.78 (1.94 to 4.45) n = 10 | 0.002 |
 %FVC (%) | 65.55 (39.85 to 84.02) n = 39 | 64.90 (47.20 to 82.66) n = 18 | 51.33 (33.34 to 81.62) n = 11 | 73.70 (57.00 to 87.90) n = 10 | 0.008 |
 VC (L) | 2.49 (1.33 to 3.05) n = 39 | 2.42 (1.43 to 3.15) n = 18 | 1.64 (0.83 to 3.16) n = 11 | 2.85 (2.08 to 4.32) n = 10 | 0.002 |
 %VC (%) | 70.70 (44.60 to 90.22) n = 39 | 67.35 (47.00 to 93.18) n = 18 | 52.00 (35.16 to 81.33) n = 11 | 81.11 (59.91 to 119.41) n = 10 | 0.004 |
 DLco (mL/min/mmHg) | (3.85 to 11.35) n = 30 | 6.44 (3.73 to 12.53) n = 16 | 7.74 (2.92 to 11.51) n = 7 | 8.04 (4.08 to 10.09) n = 7 | 0.959 |
 %DLco (%) | 29.90 (16.55 to 40.02) n = 30 | 25.35 (16.05 to 52.77) n = 16 | 33.70 (12.40 to 45.50) n = 7 | 32.41 (18.11 to 44.42) n = 7 | 0.951 |
Serum markers | |||||
 KL-6 (IU/L) | 1117 (572 to 2701) n = 79 | 1312 (692 to 2663) n = 34 | 1019 (222 to 3509) n = 25 | 1372 (659 to 3528) n = 20 | 0.166 |
 SP-D (mg/dL) | 364 (45 to 2711) n = 63 | 370 (77 to 2430) n = 29 | 320 (20 to 1170) n = 20 | 370 (133 to 3180) n = 14 | 0.328 |
 LDH (IU/L) | 365 (193 to 539) n = 79 | 346 (193 to 546) n = 34 | 327 (201 to 765) n = 25 | 436 (175 to 652) n = 20 | 0.060 |
 WBC (/μL) | 10,700 (6300 to 15,400) n = 79 | 10,400 (6200 to 17,880) n = 34 | 10,600 (5700 to 22,900) n = 25 | 12,600 (2500 to 22,900) n = 20 | 0.918 |
 CRP (mg/dL) | 8.5 (0.7 to 25) n = 79 | 7.3 (0.7 to 22) n = 34 | 11.1 (0.87 to 36) n = 25 | 7.5 (1.3 to 25.3) n = 20 | 0.063 |
 Procalcitonin (ng/mL) | 0.12 (0.01 to 0.74) n = 70 | 0.15 (0.01 to 0.58) n = 32 | 0.33 (0.07 to 0.74) n = 21 | 0.09 (0.01 to 0.31) n = 17 | 0.037 |
 D-dimer (mg/dL) | 3.6 (1.38 to 74.2) n = 74 | 3 (1.8 to 83) n = 31 | 2.6 (1.3 to 21.1) n = 24 | 6.1 (1.2 to 41.0) n = 19 | 0.222 |